MYRIAD GENETICS INC (MYGN) › RevenueMYRIAD GENETICS INC (MYGN) — RevenueAnnual figures by fiscal year, from SEC filings.2015: $722.50M2016: $740.50M2017: $728.70M2018: $743.70M2019: $851.10M2020: $557.10M2021: $690.60M2022: $678.40M2023: $753.20M2024: $837.60M2025: $824.50M$824.50M2015Revenue (USD)2025Fiscal YearRevenueChange YoY2025$824.50M-1.6%2024$837.60M+11.2%2023$753.20M+11.0%2022$678.40M-1.8%2021$690.60M+24.0%2020$557.10M-34.5%2019$851.10M+14.4%2018$743.70M+2.1%2017$728.70M-1.6%2016$740.50M+2.5%2015$722.50M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share